Injective vs SUPRA — how do they compare? Injective trades at Rp93,833 (market cap Rp9,29T, Rp1,86T 24h volume), while SUPRA trades at Rp3.75 (market cap Rp122,45M, Rp4,97M 24h volume). The key difference: Injective is far larger — about 75867.7× SUPRA's market cap, and SUPRA's supply is capped (32,5B / 100B SUPRA (33%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and SUPRA for 15 Days on average.
| INJ | SUPRA | |
|---|---|---|
Market Cap | Rp9,29T | Rp122,45M |
Volume (24h) | Rp1,86T | Rp4,97M |
Circulating Supply | 100M INJ | 32,5B / 100B SUPRA (33%) |
Typical Hold Time | 36 Days | 15 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
SUPRA is currently trading at Rp3.6929 with a market cap of Rp119.88 million, showing a bearish technical signal driven by moving averages while oscillators remain neutral. The token has a circulating supply of 32.5 million out of 100 million max supply, with an average hold time of 15 days indicating moderate trader retention. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious due to strong bearish technical indicators and limited fundamental catalysts. Key opportunities include potential accumulation at current levels if network activity improves, while major risks involve low liquidity and high volatility typical of small-cap cryptocurrencies. Investors should monitor for any upcoming protocol announcements or exchange listings.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →Supra is the first blockchain built for Automatic DeFi (AutoFi), an automated financial system. As a Layer-1 solution, it supports high-speed smart contracts with integrated data and AI oracles, automation, and cross-chain messaging. This allows for innovative AutoFi features that generate revenue and redistribute it to applications and node operators, reducing reliance on block rewards over time. The Supra stack also provides AI agents with the tools needed to create and execute effective AutoFi strategies for users in a fully on-chain, secure, and autonomous manner.
Read more on SUPRA →